| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 06/21/2011 | CA2581427C Method for reducing warp potential within lumber derived from a raw material |
| 06/21/2011 | CA2521876C Method of defining the differentiation grade of tumor |
| 06/21/2011 | CA2520438C Latex reagent for adiponectin analysis and method of adiponectin analysis |
| 06/21/2011 | CA2505786C Methods for identifying risk of breast cancer and treatments thereof |
| 06/21/2011 | CA2456342C Fluorimetric determination of analytes by amine-n-oxides as redox indicators |
| 06/21/2011 | CA2424661C Allergen-microarray assay |
| 06/21/2011 | CA2419213C Improved electrical sensor |
| 06/21/2011 | CA2407556C Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy |
| 06/21/2011 | CA2405290C Vaccine against cancerous diseases |
| 06/21/2011 | CA2386471C Purification of recombinant proteins fused to multiple epitopes |
| 06/21/2011 | CA2323071C Molecules that home to various selected organs or tissues |
| 06/21/2011 | CA2320406C Methods of screening agents for activity using teleosts |
| 06/21/2011 | CA2280791C Immunological detection of prions |
| 06/21/2011 | CA2250854C Methods for the diagnosis and prognosis of cancer |
| 06/21/2011 | CA2171336C Recombinant il4 antibodies useful in treatment of il4 mediated disorders |
| 06/18/2011 | CA2725518A1 Trigger assay for differentiating between rheumatic and non-rheumatic disorders |
| 06/16/2011 | WO2011072296A2 Food safety indicator |
| 06/16/2011 | WO2011072258A1 Pi3k/akt pathway subgroups in cancer: methods of using biomarkers for diagnosis and therapy |
| 06/16/2011 | WO2011072247A2 Pathogen restriction factors |
| 06/16/2011 | WO2011072205A2 Genetic markers indicative of a cancer patient response to trastuzumab (herceptin) |
| 06/16/2011 | WO2011072197A2 Detection of oxidized polypeptides |
| 06/16/2011 | WO2011072167A1 Electrotransfer cassette with integrated electrical contacts and locking mechanism |
| 06/16/2011 | WO2011072065A2 Microbially-based sensors for environmental monitoring |
| 06/16/2011 | WO2011072007A2 Methods and compositions for detection and identification of organophosphorus nerve agents, pesticides and other toxins |
| 06/16/2011 | WO2011071943A1 Peptide display arrays |
| 06/16/2011 | WO2011071935A2 Methods for diagnosing and assessing risk of developing glomerulosclerosis |
| 06/16/2011 | WO2011071923A2 Multi-sample indexing for multiplex genotyping |
| 06/16/2011 | WO2011071912A1 Label-free cellular manipulation and sorting via biocompatible ferrofluids |
| 06/16/2011 | WO2011071893A1 Diagnostic biomarker to identify women at risk for preterm delivery |
| 06/16/2011 | WO2011071722A1 Methods of inhibiting metastatic cancer by administration of streptolysin o |
| 06/16/2011 | WO2011071713A1 Method for assessing the damage of keratin fibers |
| 06/16/2011 | WO2011071574A2 Monoclonal antibodies against glycoprotein of ebola sudan boniface virus |
| 06/16/2011 | WO2011071447A1 Molecular imprints |
| 06/16/2011 | WO2011071368A1 Method for measuring hepcidin |
| 06/16/2011 | WO2011071364A2 A specimen collecting and testing apparatus |
| 06/16/2011 | WO2011071343A2 Heterodimer core-shell nanoparticle in which raman-active molecules are located at a binding portion of a nanoparticle heterodimer, use thereof, and method for preparing same |
| 06/16/2011 | WO2011071297A2 Composition for analyzing the pluripotency of pig stem cells |
| 06/16/2011 | WO2011071262A2 Microfluidic device comprising microchannel where protrusions are formed on bottom surface |
| 06/16/2011 | WO2011071256A2 Centrifugal micro-fluidic structure for measuring glycated hemoglobin, centrifugal micro-fluidic device for measuring glycated hemoglobin, and method for measuring glycated hemoglobin |
| 06/16/2011 | WO2011071155A1 Method for detection of basic peptide and reagent for detection of basic peptide |
| 06/16/2011 | WO2011071149A1 Method for determination of diseases based on iga hinge o-linked sugar chain structure |
| 06/16/2011 | WO2011071099A1 Anticancer anti-mortalin peptide antibodies |
| 06/16/2011 | WO2011071083A1 Molecular probe for imaging of pancreatic islet, and use thereof |
| 06/16/2011 | WO2011071021A1 Tag peptide |
| 06/16/2011 | WO2011070687A1 Device for detecting sulfur component |
| 06/16/2011 | WO2011070572A2 Method and device for detection of nitroamines |
| 06/16/2011 | WO2011070545A1 Virally induced biofilm-like structure and uses thereof |
| 06/16/2011 | WO2011070535A1 Integrated sensor for humidity, temperature and pressure in exhaust gas |
| 06/16/2011 | WO2011070485A1 Gas measurement module for use in therapeutic settings comprising reflective scanning microspectrometer |
| 06/16/2011 | WO2011070408A2 Electro-chemical sensor |
| 06/16/2011 | WO2011070369A1 Inhibitors of hemopoietic cell kinase (p59-hck) and their use in the treatment of influenza infection |
| 06/16/2011 | WO2011070333A2 Probes |
| 06/16/2011 | WO2011070174A1 Methods and reagents for improved detection of amyloid beta peptides |
| 06/16/2011 | WO2011070150A1 Novel targets for the treatment of proliferative diseases |
| 06/16/2011 | WO2011070149A1 Sterilizing chemistry for test elements |
| 06/16/2011 | WO2011070088A1 Anti-c4.4a antibodies and uses thereof |
| 06/16/2011 | WO2011070059A1 Methods of detecting dna damage |
| 06/16/2011 | WO2011069992A2 Muteins of human lipocalin 2 (lcn2, hngal) with affinity for a given target |
| 06/16/2011 | WO2011069976A1 Means for detecting luminescent and/or light-scattering particles in flowing liquids |
| 06/16/2011 | WO2011069913A1 Method for screening active agents that stimulate the expression of cert to improve the skin's barrier function |
| 06/16/2011 | WO2011069743A1 Electrochemical sensing method |
| 06/16/2011 | WO2011069614A1 Antibody that binds to h-1 parvovirus |
| 06/16/2011 | WO2011069540A1 Filtering device |
| 06/16/2011 | WO2011069518A1 Lubricated system with lubricant analyzer comprising a microfluidic chip |
| 06/16/2011 | WO2011069347A1 Method for detecting cloud point and free sugar buffer coefficient of iron-carbohydrate complex |
| 06/16/2011 | WO2011048503A3 Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof |
| 06/16/2011 | WO2011048378A3 A sensor apparatus and method for embedding in construction material |
| 06/16/2011 | WO2011047265A4 Resonance energy transfer assay with synaptobrevin substrate moiety |
| 06/16/2011 | WO2011047146A3 Methods of affinity maturing antibodies |
| 06/16/2011 | WO2011047011A3 Treatment and diagnosis of inflammatory disorders |
| 06/16/2011 | WO2011045396A3 Biomarkers of tumor pharmacodynamic response |
| 06/16/2011 | WO2011045166A9 Fkbp52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction |
| 06/16/2011 | WO2011044311A3 Generation, characterization and uses thereof of anti-her 3 antibodies |
| 06/16/2011 | WO2011042628A9 Chemical species optical sensor operating in infrared |
| 06/16/2011 | WO2011029954A3 Polypeptide marker for diagnosing and assessing vascular diseases |
| 06/16/2011 | WO2011028358A3 System and method for detecting healing adjacent to implanted medical device |
| 06/16/2011 | WO2011028195A3 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 06/16/2011 | WO2011024146A3 Adam12 inhibitors and their use against inflammation-induced fibrosis |
| 06/16/2011 | WO2011022254A3 Capacitive oil quality monitoring sensor with fluorinated barrier coating |
| 06/16/2011 | WO2011020529A3 Antibodies for the detection of integrin complexes in ffpe material |
| 06/16/2011 | WO2011020011A3 Droplet actuator and droplet-based techniques |
| 06/16/2011 | WO2011019932A9 Compositions and methods for the therapy and diagnosis of influenza |
| 06/16/2011 | WO2011019822A3 Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products |
| 06/16/2011 | WO2011017537A3 High throughput screen for measuring membrane effects |
| 06/16/2011 | WO2011014674A3 Microfluidic device for pharmacokinetic-pharmacodynamic study of drugs and uses thereof |
| 06/16/2011 | WO2011014648A3 METHODS AND SYSTEM FOR DETECTING SOLUBLE AMYLOID-β |
| 06/16/2011 | WO2011008262A9 Methods and apparatus for diagnosis and/or prognosis of cancer |
| 06/16/2011 | WO2011005893A3 Biomarkers and methods for detecting alzheimer's disease |
| 06/16/2011 | WO2011002977A3 Genetically encoded photomanipulation of protein and peptide activity |
| 06/16/2011 | WO2010121013A3 Molecularly imprinted polymers for detecting hiv-1 |
| 06/16/2011 | WO2010089587A3 Method and apparatus for measuring fluorescence in liquids |
| 06/16/2011 | US20110145941 Antibodies and derivatives thereof |
| 06/16/2011 | US20110145936 Genetically Modified Rat Models for Pharmacokinetics |
| 06/16/2011 | US20110144921 Greenhouse gas emission trading system, greenhouse gas emission trading apparatus, greenhouse gas emission trading method and program |
| 06/16/2011 | US20110144920 Method, system and device for enhancing flow field data |
| 06/16/2011 | US20110144919 Biomarker normalization |
| 06/16/2011 | US20110144914 Biomarker assay for diagnosis and classification of cardiovascular disease |
| 06/16/2011 | US20110144593 Sampler Cap |
| 06/16/2011 | US20110144206 Use of a cox-2 inhibitor for the treatment of a cox-2 dependent disorder in a patient not carrying hla alleles associated with hepatotoxicity |
| 06/16/2011 | US20110144205 Blood Glutathione as a Biomarker for Screening Asymptomatic Patients at Risk for Heart Failure |